Search results
Results From The WOW.Com Content Network
Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
L. Leiner Health Products. Lexicon Pharmaceuticals. Ligand Pharmaceuticals. List of biotech and pharmaceutical companies in the New York metropolitan area. Locus Biosciences. Lundbeck Seattle Biopharmaceuticals.
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
Alcon relocated its headquarters to Geneva in 2018, citing an opportunity to “increase Alcon’s global scale and reach to better serve customers.” The company employs a total of 25,000 people.
Name Location Security level Capacity Type(s) of offenders Arrendale State Prison: Alto: Special mission 1490 Adult & juvenile females Augusta State Medical Prison: Grovetown: Close, special mission 1326 Adult males Baldwin State Prison: Hardwick: Close 981 Adult males Burruss Correctional Training Center: Forsyth: Medium 708 Adult & juvenile males
In early 2023, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new Alzheimer’s drug called Leqembi. (Biogen, a biotechnology company, and Eisai, a pharmaceutical ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Help; Learn to edit; Community portal; Recent changes; Upload file